aTyr Pharma disclosed insider trading to the SEC on August 8, 2026, coinciding with Freedom Capital raising its rating on the company and Paul Schimmel purchasing shares.

The entities involved

• aTyr Pharma →

  company in San Diego, United States

  • Cantor Fitzgerald reiterated an Overweight rating for aTyr Pharma on August 20, 2025.Sun 04:59
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12
• Freedom Capital →

  company in the Czech Republic

  • Rating upgrades and restatements on ASML shares, including an upgrade from hold to strong-buy, were announced.Sun 18:16
  • Director Kang Lee sold company shares and Freedom Capital upgraded Photronics shares on September 24, 2026.Fri 05:43

Related events

• Alnylam Pharmaceuticals, SEC, Truist Financial, and Nasdaq were involved in insider trading disclosures, analyst ratings, and stock trading on June 6, 2026.Jun 10
• Newell Brands stock trades on the electronic exchange and discloses insider transactions with the SEC.Aug 27
• Invivyd, Inc. disclosed insider trading filings with the SEC, while trading on the Nasdaq stock exchange.Aug 19
• Insider trading and institutional ownership changes related to Madrigal Pharmaceuticals were disclosed to the SEC.Sep 10
• The CFO of Coherent sold company shares, with the insider trading reported via SEC Form 4.Sep 4